DEXCOM INC Quarterly Debt-to-equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Dexcom Inc quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2024.
  • Dexcom Inc Debt-to-equity for the quarter ending September 30, 2024 was 197 %, a 10.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 197 +18.2 +10.2% Sep 30, 2024
Q2 2024 190 +16.9 +9.79% Jun 30, 2024
Q1 2024 201 +52.4 +35.1% Mar 31, 2024
Q4 2023 191 +45.9 +31.7% Dec 31, 2023
Q3 2023 179 +36.6 +25.8% Sep 30, 2023
Q2 2023 173 +37.7 +27.9% Jun 30, 2023
Q1 2023 149 +10.9 +7.88% Mar 31, 2023
Q4 2022 145 +1.67 +1.17% Dec 31, 2022
Q3 2022 142 -5.2 -3.54% Sep 30, 2022
Q2 2022 135 Jun 30, 2022
Q1 2022 138 Mar 31, 2022
Q4 2021 143 Dec 31, 2021
Q3 2021 147 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.